Feb 24 (Reuters) - Intellipharmaceutics International Inc I.TO
* Intellipharmaceutics announces FDA approval for 500 mg and 750 mg generic Glucophage XR
* Intellipharmaceutics International Inc - actively evaluating options to realize commercial returns from new approval Source text for Eikon: ID:nGNXNQJKQa Further company coverage: I.TO